Analystreport

Radius Health, Inc. (NASDAQ: RDUS) had its "buy" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $33.00 price target on the stock.

Radius Recycling, Inc. - Class A  (RDUS) 
Last radius recycling, inc. - class a earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.radiuspharm.com